FDA Clearance Tracker · P100041
EDWARDS SAPIEN TRANSCATHETER HEART VALVE AND ACCESSORIES
Last checked: Nov 19, 2026Latest source record: Nov 2, 2011 (this decision)Source: openFDAMethods & limitations
Decided
Nov 2, 2011
Approval withdrawn
Time to decision
366 days
Received Nov 1, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P100041
- Device name
- EDWARDS SAPIEN TRANSCATHETER HEART VALVE AND ACCESSORIES
- Applicant
- Edwards Lifesciences, LLC
- Applicant location
- Irvine, CA
- Received
- Nov 1, 2010
- Decided
- Nov 2, 2011
- Decision
- Approval withdrawn
- Expedited review
- Yes, flagged as expedited in FDA's record.
- Supplements
- 64 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE SAPIEN TRANSCATHETER HEART VALVE, MODEL 9000TFX, SIZES 23MM AND 26MM AND ACCESSORIES. THIS DEVICE IS INDICATED FOR TRANSFEMORAL DELIVERY IN PATIENTS WITH SEVERE SYMPTOMATIC NATIVE AORTIC VALVE STENOSIS WHO HAVE BEEN DETERMINED BY A CARDIAC SURGEON TO BE INOPERABLE FOR OPEN AORTIC VALVE REPLACEMENT AND IN WHOM EXISTING COMORBIDITIES WOULD NOT PRECLUDE THE EXPECTED BENEFIT FROM CORRECTION OF THE AORTIC STENOSIS.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code NPT (Aortic valve, prosthesis, percutaneously delivered).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Edwards Lifesciences, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- PASCAL Precision Transcatheter Valve Repair SystemPMA supplement
P220003-S029 · Decided Oct 20, 2026 · 180 days after receipt · Panel Track
Device type: Tricuspid valve repair device, percutaneously delivered (NPS) · Cardiology
P260007 · Decided Oct 1, 2026 · 234 days after receipt
Device type: Heart-valve, polymeric (SJL) · Cardiology
K251326 · Decided Jun 11, 2026 · 408 days after receipt
Device type: Monitor, Breathing Frequency (BZQ) · Anesthesiology & Respiratory
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.